Schedule 13D ownership disclosure

DECIPHERA PHARMACEUTICALS IN

Security class unavailable · CUSIP: 24344T101

Event date: 2018-06-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-199509
Form type
SC 13D/A
Filer
Deciphera Pharmaceuticals, Inc.
CIK
CIK 1654151
Filed
Jun 21, 2018
Reporting period
Jun 11, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub